Apple To $185? Here Are 5 Other Price Target Changes For Friday
Apple To $185? Here Are 5 Other Price Target Changes For Friday
蘋果要到 185 美元？以下是週五的其他5項目標價格變化
- Keybanc raised the price target on Apple Inc. (NASDAQ:AAPL) from $177 to $185. However, Keybanc analyst Brandon Nispel maintained the stock with an Overweight. Apple shares fell 0.9% to $172.63 in pre-market trading.
- Piper Sandler raised Globant S.A. (NYSE:GLOB) price target from $231 to $249. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating on the stock. Globant shares rose 0.2% to close at $229.90 on Wednesday.
- HC Wainwright & Co. cut Nemaura Medical Inc. (NASDAQ:NMRD) price target from $12 to $8. HC Wainwright & Co. analyst Yi Chen maintained a Buy rating on the stock. Nemaura Medical shares fell 1.4% to close at $2.17 on Thursday.
- RBC Capital reduced Enviva Inc. (NYSE:EVA) price target from $78 to $76. RBC Capital analyst Elvira Scotto also downgraded the stock from Outperform to Sector Perform. Enviva shares rose 1.4% to close at $75.79 on Thursday.
- Telsey Advisory Group raised DICK'S Sporting Goods, Inc. (NYSE:DKS) price target from $110 to $125. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating on the stock. DICK'S Sporting rose 0.2% to close at $112.47 on Thursday.
- B. Riley Securities cut Gain Therapeutics, Inc. (NASDAQ:GANX) price target from $11 to $5. B. Riley Securities analyst Mayank Mamtani also downgraded the stock from Buy to Neutral. Gain Therapeutics shares fell 2.8% to close at $3.82 on Thursday.
- KeyBanc上調了目標價蘋果。(納斯達克：蘋果)從177美元升至185美元。然而，Keybanc分析師布蘭登·尼斯佩爾維持了該股的增持。蘋果股價在盤前交易中下跌0.9%，至172.63美元。
- 派珀·桑德勒養大Globant S.A.(紐約證券交易所代碼：GLOB)目標價從231美元降至249美元。Piper Sandler分析師Arvind Ramnani對該股維持增持評級。Globant股價週三上漲0.2%，收於229.90美元。
- HC Wainwright&Co.CutNemaura Medical Inc.納斯達克(Sequoia Capital：NMRD)目標價從12美元降至8美元。HC Wainwright&Co.分析師陳毅維持對該股的買入評級。Nemaura Medical股價週四下跌1.4%，收於2.17美元。
- RBC資本減少Enviva公司(紐約證券交易所代碼：EVA)目標價從78美元降至76美元。加拿大皇家銀行資本分析師埃爾維拉·斯科託也將該股評級從表現優於大盤下調至板塊表現。Enviva股價週四上漲1.4%，收於75.79美元。
- 泰爾西諮詢小組提出迪克體育用品公司(紐約證券交易所代碼：DKS)目標價從110美元降至125美元。特爾西諮詢集團分析師約瑟夫·費爾德曼對該股維持表現優於大盤的評級。迪克體育週四上漲0.2%，收於112.47美元。
- B.萊利證券降息Gain治療公司(納斯達克股票代碼：GANX)目標價從11美元下調至5美元。萊利證券分析師Mayank Mamtani也將該股評級從買入下調至中性。Gain Treateutics股價週四下跌2.8%，收於3.82美元。
Check out this: U.S. Stock Futures Down Ahead Of Earnings; Crude Oil Drops
看看這個：美國股指期貨在盈利之前下跌；原油下跌